Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414180 · ClinicalTrials.gov registry record · Phase 3
Bupropion SR for Treating Smokeless Tobacco Use
A Phase 3 study of Smokeless Tobacco, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 225
- Enrollment target
- 1
- Study location
NCT00414180: Completed Phase 3 study of Smokeless Tobacco, sponsored by Mayo Clinic.
NCT00414180 is a Phase 3 study of Smokeless Tobacco that has completed, run by Mayo Clinic. The registered enrollment target is 225 participants, above the 168-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00414180, a Phase 3 study of Smokeless Tobacco, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.
Conditions Studied
Interventions
- DRUG Bupropion SR
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-05 |
| Phase | Phase 3 |
What the finished NCT00414180 record still lists
NCT00414180 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, above the 168-participant average among 3 other Smokeless Tobacco trials with a reported enrollment target (34% higher).
The record links to 1 condition, with Smokeless Tobacco appearing as the primary indexed condition, and to 1 intervention - of which Bupropion SR is the first listed.
NCT00414180 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00414180 about?
NCT00414180 is a clinical study titled "Bupropion SR for Treating Smokeless Tobacco Use". To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.
What is the current status of trial NCT00414180?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 225 participants. The study started on 2003-08. Estimated completion is 2005-05.
What conditions does trial NCT00414180 study?
This clinical trial studies the following conditions: Smokeless Tobacco.
What interventions are being tested in trial NCT00414180?
The interventions under investigation include: Bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00414180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00414180 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smokeless Tobacco
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
RECRUITING · NA
-
Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
ACTIVE NOT RECRUITING · Phase 1
-
Telephone Counseling for Snuff Users
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia